WASHINGTON (AP) — A new class of experimental medicines have shown to dramatically lower cholesterol, raising hopes of a fresh option for people who can’t tolerate or don’t get enough help statin drugs, like Lipitor, […]
Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines.
Ranbaxy Pharmaceuticals Inc. is recalling more than 40 lots of atorvastatin pills — the generic version of the popular statin Lipitor — over possible glass contamination.
Cheaper generic versions of the popular cholesterol lowering drug Lipitor will soon be hitting the market. Pfizer Inc.’s patent protection for Lipitor expires on Wednesday.